RxDoctor Payments DataLook up a doctor →

Rishi Kakar

Psychiatry · Tamarac, FLNPI 1184821928

Payments from drug & device makers

$23,856,145in general payments, 2019–2025

Across 2,946 payments — averaging $8097.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$6.5M
  • AbbVie$4.3M
  • Teva Pharmaceuticals USA, Inc.$3.4M
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$2.4M
  • Vanda Pharmaceuticals Inc.$1.9M
  • E.r. Squibb & Sons, L.L.C.$1.2M
  • plus $4.1M from 28 others
$4,695in research payments, 2019–2025

Across 21 payments — averaging $223.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Otsuka Pharmaceutical Development & Commercialization, Inc.$3K
  • Eli Lilly$1K
  • AbbVie$3

What the payments were for

  • Consulting fees$12,01313%
  • Speaking & faculty fees$72,57678%
  • Travel & lodging$5,5196%
  • Food & beverage$3,3724%
  • Education$1260%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)839$6,524,460
AbbVie(2 entities)585$4,342,251
Teva Pharmaceuticals USA, Inc.231$3,378,517
Otsuka Pharmaceutical Development & Commercialization, Inc.38$2,447,710
Vanda Pharmaceuticals Inc.20$1,850,252
E.r. Squibb & Sons, L.L.C.16$1,173,653
Hoffmann-la Roche Limited55$894,429
Indivior Inc.163$536,344
Alkermes, Inc.312$530,659
Sage Therapeutics, LLC122$420,601
Roche TCRC, Inc.53$412,900
Sunovion Pharmaceuticals Inc.139$287,778
Biogen4$283,663
Boehringer Ingelheim7$150,981
GW Research Limited51$126,617
Biohaven Pharmaceuticals, Inc.26$74,067
Merck3$67,499
Supernus Pharmaceuticals, Inc.16$64,100
Imbrium Therapeutics L.p.27$58,783
Otsuka America Pharmaceutical, Inc.60$55,838
Livanova USA, Inc.28$39,117
Mallinckrodt LLC11$23,177
Johnson & Johnson35$21,384
Jazz Pharmaceuticals Inc.13$17,067
Acadia Pharmaceuticals Inc53$15,464
Janssen Research & Development, LLC4$14,274
Eisai Inc.8$11,643
Biohaven Pharmaceutical Holding Company Ltd.5$7,925
Sumitomo Pharma America, Inc.5$7,867
H. Lundbeck A S2$5,952
Boehringer Ingelheim Pharma GmbH & Co.kg2$5,654
F. Hoffmann-la Roche AG1$2,405
Neurocrine Biosciences, Inc.11$1,623
Boehringer Ingelheim International GmbH1$1,493

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$23,856,145 in reported general payments places this provider in the 95th percentile of 2,059 psychiatry providers in Florida.

See all psychiatry providers in Florida →

Other psychiatry in Tamarac

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →